Recruiting
Phase 1

Phase 1 Trial of ST-001 NanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

Sponsor:

SciTech Development, LLC

Code:

NCT04234048

Conditions

T-cell Lymphoma

Cutaneous/Peripheral T-Cell Lymphoma

Peripheral T-cell Lymphoma

Peripheral T-Cell Lymphoma, Not Classified

Primary Cutaneous T-cell Lymphoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Fenretinide

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information